SKAN Group (BATS-CHIXE:SKANZ) - Stock Price, News & Analysis

SKANZ Stock Overview

SKANZ fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	4/6
Past Performance	4/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 17.2% below our estimate of its fair value

Earnings are forecast to grow 34.77% per year

Earnings grew by 38.6% over the past year

Risk Analysis

High level of non-cash earnings

SKAN Group AG Competitors

Ergomed

AIM:ERGO

UK£701.1m

hVIVO

AIM:HVO

UK£189.1m

Genus

LSE:GNS

UK£1.1b

C4X Discovery Holdings

AIM:C4XD

UK£30.3m

Price History & Performance

Summary of all time highs, changes and price drops for SKAN Group
Historical stock prices
Current Share Price	CHF81.90
52 Week High	CHF87.60
52 Week Low	CHF64.70
Beta	0.91
1 Month Change	-3.31%
3 Month Change	8.48%
1 Year Change	-2.50%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	56.00%

Recent updates

Shareholder Returns

	SKANZ	GB Life Sciences	GB Market
7D	1.0%	-2.2%	1.1%
1Y	-2.5%	-44.5%	1.9%

Return vs Industry: SKANZ exceeded the UK Life Sciences industry which returned -45.7% over the past year.

Return vs Market: SKANZ underperformed the UK Market which returned 2.3% over the past year.

Price Volatility

Is SKANZ's price volatile compared to industry and market?
SKANZ volatility
SKANZ Average Weekly Movement	3.0%
Life Sciences Industry Average Movement	5.8%
Market Average Movement	4.8%
10% most volatile stocks in GB Market	11.5%
10% least volatile stocks in GB Market	2.7%

Stable Share Price: SKANZ has not had significant price volatility in the past 3 months.

Volatility Over Time: SKANZ's weekly volatility (3%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1968	1,428	GL Huber	skan.com/de/home/

SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. It operates in two segments: Equipment and Solutions and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar flow, particle counter, personal protective equipment, safety workbench, transfer systems, and fume cupboard.

SKAN Group AG Fundamentals Summary

How do SKAN Group's earnings and revenue compare to its market cap?
SKANZ fundamental statistics
Market cap	CHF1.84b
Earnings (TTM)	CHF26.31m
Revenue (TTM)	CHF320.02m

69.9x

P/E Ratio

5.7x

P/S Ratio

Is SKANZ overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SKANZ income statement (TTM)
Revenue	CHF320.02m
Cost of Revenue	CHF85.94m
Gross Profit	CHF234.08m
Other Expenses	CHF207.77m
Earnings	CHF26.31m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Aug 20, 2024

Earnings per share (EPS)	1.17
Gross Margin	73.15%
Net Profit Margin	8.22%
Debt/Equity Ratio	3.6%

How did SKANZ perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

30%

Payout Ratio

Does SKANZ pay a reliable dividends?

See SKANZ dividend history and benchmarks

When do you need to buy SKANZ by to receive an upcoming dividend?
SKAN Group dividend dates
Ex Dividend Date	May 10 2024
Dividend Pay Date	May 14 2024
Days until Ex dividend	8 days
Days until Dividend pay date	12 days